The trademark application 180 THERAPEUTICS was filed by 180 LIFE SCIENCES CORP., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 7, 2022, and it was registered by office on December 15, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Analgesic preparations
Pharmaceutical preparations for the treatment of inflammatory diseases
Pharmaceutical preparations for the treatment of inflammation
Pharmaceutical preparations for the treatment of dupuytren's disease
Pharmaceutical preparations for the treatment of frozen shoulder
Pharmaceutical preparations for the treatment of post-operative delirium
Pharmaceutical preparations for the treatment of post-operative cognitive deficit
Pharmaceutical preparations for the treatment of post-operative cognitive decline
Pharmaceutical preparations for the treatment of non-alcoholic steatohepatitis
Pharmaceutical preparations for the treatment of fibrosis
Pharmaceutical preparations for the treatment of liver fibrosis
Pharmaceutical preparations for the treatment of arthritis
Pharmaceutical preparations for the treatment of pain
Pharmaceutical preparations for the treatment of ulcerative colitis
Pharmaceutical preparations for the treatment of anxiety
Pharmaceutical preparations for the treatment of type 1 diabetes
Pharmaceutical preparations for the treatment of type 2 diabetes
Pharmaceutical preparations for inhibition of tumor necrosis factor (tnf)
Pharmaceutical preparations for interacting with nicotine receptors
Pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (cbd)
Pharmaceutical preparations for liver regeneration
Pharmaceutical preparations for regenerative therapy
Pharmaceutical preparations for acting as an alpha-7nachr agonist.
The mark was filed in class 42 with following description of goods:
Development of pharmaceutical preparations and medicines
Pharmaceutical drug development services
Pharmaceutical product evaluation
Pharmaceutical research and development
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Research and development in the pharmaceutical and biotechnology fields
Scientific research for medical purposes in the field of inflammatory diseases
Scientific research for medical purposes in the field of treatment of inflammation
Scientific research for medical purposes in the field of dupuytren's disease
Scientific research for medical purposes in the field of frozen shoulder
Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline
Scientific research for medical purposes in the field of non-alcoholic steatohepatitis
Scientific research for medical purposes in the field of fibrosis
Scientific research for medical purposes in the field of liver fibrosis
Scientific research for medical purposes in the field of arthritis
Scientific research for medical purposes in the field of pain treatment
Scientific research for medical purposes in the field of ulcerative colitis
Scientific research for medical purposes in the field of treatment of anxiety
Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (tnf) and anti-tnf pharmaceuticals
Scientific research for medical purposes in the field of interactions with nicotine receptors
Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (cbd)
Scientific research for medical purposes in the field of synthetic cannabidiol (cbd) analogs
Scientific research for medical purposes in the field of type 1 diabetes
Scientific research for medical purposes in the field of type 2 diabetes
Scientific research for medical purposes in the field of liver regeneration
Scientific research for medical purposes in the field of regenerative therapy
Scientific research for medical purposes in the field of alpha-7nachr agonists.